The Effect of a Mindfulness-Based Stress Reduction Program in Patients With Multiple Sclerosis
1 other identifier
interventional
30
1 country
1
Brief Summary
The aim of this study is to investigate the effect of an mindfulness-based stress reduction (MBSR) program designed in accordance with the literature and the basic principles of the program on fatigue, self-efficacy and stress for individuals with multiple sclerosis (MS). Thirty members of the Multiple Sclerosis Society with multiple sclerosis were randomized as experimental and control groups. Participants in the experimental group received an 8-week MBSR program by an MBSR instructor. The patients in the control group continued to visit the society for their scheduled examinations and controls; no intervention was given to them. Outcome measurements consisted of Fatigue Impact Scale (FIS), Self-Efficacy Scale and Perceived Stress Scale.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable multiple-sclerosis
Started Jul 2020
Shorter than P25 for not_applicable multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2020
CompletedFirst Submitted
Initial submission to the registry
May 8, 2024
CompletedFirst Posted
Study publicly available on registry
May 16, 2024
CompletedMay 16, 2024
May 1, 2024
3 months
May 8, 2024
May 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Fatigue Impact Scale
It is a multidimensional fatigue scale that is frequently used in clinical and experimental investigations to assess the impact of fatigue on the body, mind, and social interactions.
at baseline and at week 8
Self-Efficacy Scale
The scale, which does not belong to any subjective domain, measures the general perception of self-efficacy.
at baseline and at week 8
Perceived Stress Scale
The scale was developed by Cohen et al in 1983 . Consisting of 14 items in total, Perceived Stress Scale is designed to measure how stressful a person's life is perceived by certain situations.
at baseline and at week 8
Study Arms (2)
Experimental group
EXPERIMENTALParticipants in the experimental group received an 8-week MBSR program by an MBSR instructor.
Control group
NO INTERVENTIONThe patients in the control group continued to visit the society for their scheduled examinations and controls; no intervention was given to them. Furthermore, the control group received an invitation to participate in an identical MBSR program session following the study's conclusion.
Interventions
Participants in the experimental group received an 8-week MBSR program by an MBSR instructor. Each meeting were planned as a 3-hour session that completes the mindfulness training procedures by doing an opening meditation of 30- 45 minutes about that week, after the information about the meeting topic of the week is discussed. Experiences after meditation were shared with the group. Each week, the meeting topic and meditation continued with different contents, and practice meditations on the subject were held every week and home exercises were given. Home practice meditations were performed by listening to the guide audio recording with headphones. All home exercises in the training content were followed up on a daily basis and recorded.
Eligibility Criteria
You may qualify if:
- diagnosis of relapsing-remitting MS or progressive MS
- over 18 years of age,
- neurologist confirmed diagnosis of MS,
- a score of less than or equal to 7.0 on the Expanded Disability Status Scale (EDSS).
You may not qualify if:
- comorbidities with life-threatening physical or mental health (such as active psychosis, suicidal ideation, or terminal or life-threatening co-occurring medical diseases), or disorders that are predicted to severely restrict participation and adherence (e.g., dementia, pregnancy, ongoing substance abuse);
- individuals who are presently undergoing non-pharmacological psychological treatments or prior formal training in mindfulness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Halic Universitylead
Study Sites (1)
Halic University
Istanbul, Eyüpsultan, 34060, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
İrem Çetinkaya, PhD
Halic University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 8, 2024
First Posted
May 16, 2024
Study Start
July 1, 2020
Primary Completion
October 1, 2020
Study Completion
November 15, 2020
Last Updated
May 16, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share